US Patent Litigations are now available. Check here

Explore Angiobiomed's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 10, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3082858Jan 27, 2021Adrenomedullin Binder For Use In Therapy Of Cancer1